The page is the record's research on the issuer — no analyst, no rating, no view.

Helix BioPharma Corp. (HBP) — research page

CA · ca-cm-kg/TSX/HBP · as of 2026-11-06

Identity and listing

Helix BioPharma Corp. is listed on the TSX under ticker HBP. Its ISIN is CA4229102088 and its LEI is 9845005F4A1779D70B60. Its security type is Corporate, its segment is not on the record, its sector is Life Sciences, and its jurisdiction is Canada (federal) (CA). Its listing status is listed, not halted.

fieldvaluesource · read date
nameHelix BioPharma Corp.source · 2026-11-06
exchangeTSXsource · 2026-11-06
tickerHBPsource · 2026-11-06
ISINCA4229102088source · 2026-11-06
LEI9845005F4A1779D70B60source · 2026-11-06
security typeCorporatesource · 2026-11-06
segmentnot on the record
sectorLife Sciencessource · 2026-11-06
jurisdictionCanada (federal) (CA)source · 2026-11-06
statuslisted, not haltedsource · 2026-11-08

The disclosure read

The record holds 9 filings on 8 filing days in the twelve months to 2026-11-06, of which 3 are financial statements and 6 are newswire releases. The median gap between filing days is 25 days. The record date is 2026-11-06, and the latest filing is a financial statement dated 2026-10-30, 7 days before the record date. The TSX median cadence gap is 16 days and its median latency is 3.0 days, with a median of 0.0 filings. The Life Sciences median cadence gap is 17.5 days, its median latency is 14 days, and its median filings are 7.0.

filingsmedian gap between filing daysdays from latest filing to as-of
this issuer9257
exchange median: TSX (2270 issuers)0163
sector median: Life Sciences (200 issuers)717.514
datetypecategoryfiling
2026-10-30financial_statementHelix BioPharma Corp. Announces Fiscal 2026 Year-End Results
2026-10-30newswire_releaseHelix BioPharma Corp. Announces Fiscal 2026 Year-End ...
2026-10-29financial_statementHelix BioPharma Corp. Announces Fiscal 2026 Year-End Results
2026-08-17newswire_releaseHelix BioPharma Corp. Appoints Markus Loeffler, MD, MBA, as Chief Medical Officer to Support Next Phase of Clinical Development
2026-08-14newswire_releaseHelix Biopharma Corp. Announces Board Composition Changes

window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor of record is not on the record, and no auditor was found. Its location is not on the record. The record holds no auditor changes.

Events and halts

The record holds no listing, delisting, name change, domicile change or segment move events. The index does not carry a halt event; the issuer is listed, not halted.

Orderability

Under paragraph (o) of the definition, the signal is ACM-200 and the outcome is determinable. Under paragraph (q) of the definition, the signal is ACM-200 and the outcome is determinable. The rule version is acm-68000/ca/kyp-know-your-product-ni-31-103/r1, and the chapter is as of 2026-11-04.

client categoryoutcome
Paragraph (o) of the definitionACM-200
Paragraph (q) of the definitionACM-200

rule acm-68000/ca/kyp-know-your-product-ni-31-103/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

The field has not been read, so the research houses named on the issuer's investor-relations page are not on the record.

Open research

The field has not been read, so openly published research notes are not on the record.

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

licensorentitlementtitledatesource
none loaded

As-of depth

The market's vintage is not sealed. No issuer years are sealed, and the market's earliest sealed date is not on the record. The live record began 2026-09-10. The store holds 2021, 2022, 2023, 2024, 2025 and 2026 as sealed years, but none are served as of a date, and the as-of door answers not_sealed.

Sources

8 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1
https://www.tsx.com/json/company-directory/search/tsx/^* (identity.exchange)
10.2
https://jp.investing.com/equities/helix-biopharma-corp. (identity.isin)
10.3
https://api.gleif.org/api/v1/lei-records/9845005F4A1779D70B60 (identity.jurisdiction)
10.4
https://www.tsx.com/en/resource/571 (identity.sector)
10.5
https://mcp.ca-cm-kg.ai/events/TSX/HBP (the disclosure lines)
10.6
https://iiroc.mediaroom.com/index.php?s=2429&l=100 (the halt flag)
10.7
https://mcp.ca-cm-kg.ai/book/aio.json (the orderability chapter)
10.8
https://mcp.ca-cm-kg.ai/record/TSX/HBP (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"CA4229102088"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:6076b4d3a79f24a7.